Lugar de publicación
- Selective TASK-1 Inhibitor with a Defined Structure-Activity Relationship Reduces Cancer Cell Proliferation and Viability. 65(22):15014-15027. 2022
- TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. 65(2):1585-1607. 2022
- COVID-19: Drug Targets and Potential Treatments. 63(21):12359-12386. 2020
- TASK Channels Pharmacology: New Challenges in Drug Design. 62(22):10044-10058. 2019
- Factors Determining the Superior Performance of Lipid/DNA/Protammine Nanoparticles over Lipoplexes. 54(12):4160-4171. 2011
- Historical and Current Perspectives of Neuroactive Compounds Derived from Latin America. 6:997-1008. 2006